This inventor holds 1 USPTO granted patent. Top assignees: Daewood Co., Ltd., Dong-A Pharm. Co., Ltd., Genexine, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 12 
1 out of 24 Years Active: 2011
Title: Jin-Won Youn: Innovator in Hepatitis C Vaccine Development
Introduction
Jin-Won Youn is a notable inventor based in Incheon-si, South Korea. He has made significant contributions to the field of vaccine development, particularly in enhancing protective immunity against the hepatitis C virus.
Latest Patents
Jin-Won Youn holds a patent for a vaccine that enhances protective immunity to the hepatitis C virus using plasmid DNA and recombinant adenovirus. This innovative vaccine comprises a core-E1-E2 expressing DNA vaccine, nonstructural protein NS3 and NS4 expressing DNA vaccines, and a nonstructural protein NS5 expressing DNA vaccine. The method of administration involves priming with the aforementioned DNA vaccines and boosting with the recombinant adenovirus vaccine, thereby enhancing immunity against the hepatitis C virus.
Career Highlights
Throughout his career, Jin-Won Youn has worked with prominent organizations such as Genexine, Inc. and Postech Foundation. His work has been pivotal in advancing research and development in the field of immunology.
Collaborations
Jin-Won Youn has collaborated with notable colleagues, including Young Chul Sung and Se-Hwan Yang, contributing to various research initiatives and projects.
Conclusion
Jin-Won Youn's innovative work in vaccine development showcases his commitment to enhancing public health through scientific research. His contributions are vital in the ongoing fight against hepatitis C virus.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile